TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.52 B vs $2.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TMDX | AXGN |
|---|---|---|
| Market cap | $2.52 B | $2.29 B |
| US-listed rank | #1961 | #2021 |
| Revenue (latest FY) | $605.49M | $225.21M |
| Net income (latest FY) | $190.30M | -$15.70M |
| Net margin | 31.4% | -7.0% |
| P/E (trailing FY) | 13.2 | - |
| SEC filings | 615 | 1,334 |
TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.52 B vs $2.29 B).
In their latest fiscal years, TransMedics Group, Inc. reported $605.49M in revenue while Axogen, Inc. reported $225.21M.
Full pages: TransMedics Group, Inc. and Axogen, Inc., or browse the full rankings.